VBIO
Valion Bio, Inc. · Healthcare · Biotechnology
TECHSell
R500#26 today
$2.59
+3.19% today · -14.52% 1W
Oct 2 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- VBIO +3.19% on the last session vs SPY +0.74%: +2.4 pts of stock-specific move.
- 0 Reddit mentions in the past 24 hours, 73% positive over the week.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
—
not scheduled yet
EPS estimate
—
Revenue estimate
—
Track record
4/6 beats
last 6 reports · moved ±11.6% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 AMC | 3Q2023 | −$2,975.00 | −$629.00 | +$2,346.00 (+78.9%) beat | $282,000 | -13.8% -14.0 vs SPY | -17.4% | +5.0% |
| Aug 14, 2023 AMC | 2Q2023 | −$3,400.00 | −$2,975.00 | +$425.00 (+12.5%) beat | $161,000 | -7.5% -6.3 vs SPY | -5.0% | +47.5% |
| May 15, 2023 AMC | 1Q2023 | −$4,675.00 | −$4,675.00 | $0.00 (0.0%) in line | $376,000 | -31.1% -30.4 vs SPY | -30.0% | -38.4% |
| Mar 31, 2023 BMO | 4Q2022 | −$13,175.01 | −$9,775.00 | +$3,400.00 (+25.8%) beat | $408,000 | -13.2% -14.6 vs SPY | -12.6% | -21.8% |
| Nov 14, 2022 BMO | −$13,600.01 | −$11,475.01 | +$2,125.00 (+15.6%) beat | — | 0.0% +0.8 vs SPY | -2.4% | -7.8% | |
| Aug 15, 2022 — | −$10,200.01 | −$13,600.01 | −$3,400.00 (−33.3%) miss | — | -3.9% -4.1 vs SPY | -2.0% | -6.4% |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Dec 31, 2023 | — | — | — | ||||
| Next quarter | — | — | — | ||||
| Current year · Dec 31, 2023 | — | — | — | ||||
| Next year | — | — | — |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.